Matthew Johnson

Patent Director

Matthew specializes in the pharmaceutical, life science and chemical industries and has considerable experience of patent drafting and European and worldwide patent prosecution. Matthew is also experienced in EPO oppositions and has represented clients on many occasions before the EPO’s opposition division and Technical Boards of Appeal.  

Matthew is a European and UK Patent Attorney with extensive experience relating to pharmaceutical subject matter including new chemical entities, processes, intermediates, pharmaceutical formulations, combination pharmaceutical products and further medical uses.

He represents a broad variety of clients including multi-nationals, SMEs and universities, providing services including drafting patent applications for worldwide prosecution, managing patent prosecution portfolios, advising on European and foreign patent prosecution matters, EPO opposition and appeals, freedom to operate opinions and validity opinions. Matthew also has experience of obtaining Supplementary Protection Certificates (SPCs) in Europe, UK patent litigation and IP due diligence.

Besides pharmaceuticals, Matthew regularly helps clients obtain and defend patent rights in relation to agrochemicals, catalysis, polymers and food science. 

Prior to entering the patent law profession, Matthew was a medicinal chemist for 7 years at GlaxoSmithKline. His research focussed on the lead optimisation of new chemical entities for the treatment of neurological conditions. He has co-authored papers in several peer-reviewed journals and is a co-inventor on a number of patents/patent applications.